Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson's disease
Parkinson's disease (PD) is a growing burden worldwide, and there is no reliable biomarker used in clinical routines to date. Cerebrospinal fluid (CSF) is routinely collected in patients with neurological symptoms and should closely reflect alterations in PD patients’ brains. Here, we describe...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Press
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |